D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 103 Citations 35,453 582 World Ranking 3324 National Ranking 1896

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Prostate cancer, Prostate, Prostatectomy, Internal medicine and Prostate-specific antigen are his primary areas of study. His Prostate cancer study combines topics from a wide range of disciplines, such as Cancer research, Gynecology, Surgery and Urology. The study incorporates disciplines such as Immunohistochemistry, Pathology, Gene expression, Stage and Adenocarcinoma in addition to Prostate.

His Prostatectomy research integrates issues from Prostate neoplasm, Biopsy, Salvage therapy, Erectile dysfunction and Prospective cohort study. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Oncology. His Prostate-specific antigen research includes elements of Biochemical recurrence, Radiation therapy, Proportional hazards model and Retrospective cohort study.

His most cited work include:

  • Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update (972 citations)
  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes (542 citations)
  • Surrogate End Point for Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy (448 citations)

What are the main themes of his work throughout his whole career to date?

Judd W. Moul spends much of his time researching Prostate cancer, Internal medicine, Prostatectomy, Prostate and Oncology. Prostate-specific antigen is the focus of his Prostate cancer research. His Prostate-specific antigen research is multidisciplinary, incorporating elements of Salvage therapy, Proportional hazards model and Retrospective cohort study.

His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology. In his study, Hazard ratio is inextricably linked to Urology, which falls within the broad field of Prostatectomy. His Prostate study incorporates themes from Cancer research, Carcinoma, Cohort, Pathology and Adenocarcinoma.

He most often published in these fields:

  • Prostate cancer (77.72%)
  • Internal medicine (46.33%)
  • Prostatectomy (42.03%)

What were the highlights of his more recent work (between 2011-2021)?

  • Prostate cancer (77.72%)
  • Internal medicine (46.33%)
  • Oncology (31.77%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Prostatectomy and Urology. Judd W. Moul has researched Prostate cancer in several fields, including Biopsy, Prostate and Gynecology. Judd W. Moul interconnects Endocrinology and MEDLINE in the investigation of issues within Internal medicine.

His research integrates issues of Stage, Orchiectomy, Disease and Genitourinary Cancers in his study of Oncology. He combines subjects such as Proportional hazards model, Radiation therapy, Surgery and Cohort with his study of Prostatectomy. Judd W. Moul has included themes like Clinical endpoint and Hazard ratio in his Urology study.

Between 2011 and 2021, his most popular works were:

  • Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer (283 citations)
  • A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes (161 citations)
  • Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer (152 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Judd W. Moul focuses on Prostate cancer, Internal medicine, Oncology, Prostate and Urology. The various areas that he examines in his Prostate cancer study include Gynecology and Surgery. As part of his studies on Internal medicine, he often connects relevant subjects like Endocrinology.

His study in Oncology is interdisciplinary in nature, drawing from both Androgen deprivation therapy, Androgen, Disease, Biochemical recurrence and Orchiectomy. His research in Prostate intersects with topics in Stage, Newly diagnosed, Biopsy and Radiation therapy. His work in Urology addresses subjects such as Prostatectomy, which are connected to disciplines such as Erectile dysfunction, Sexual function and Retrospective cohort study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

Ian Thompson;James Brantley Thrasher;Gunnar Aus;Arthur L. Burnett.
The Journal of Urology (2007)

1274 Citations

Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men

Ted O. Morgan;Steven J. Jacobsen;William F. McCarthy;Debra J. Jacobson.
The New England Journal of Medicine (1996)

553 Citations

Surrogate End Point for Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy

Anthony V. D’Amico;Judd W. Moul;Peter R. Carroll;Leon Sun.
Journal of the National Cancer Institute (2003)

550 Citations

Frequent Detection of Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancers

Jaya P. Gaddipati;David G. McLeod;Howard B. Heidenberg;Isabell A. Sesterhenn.
Cancer Research (1994)

545 Citations

Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

Michael S. Cookson;Gunnar Aus;Arthur L. Burnett;Edith D. Canby-Hagino.
The Journal of Urology (2007)

542 Citations

Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era

Anthony V. D’Amico;Judd Moul;Peter R. Carroll;Leon Sun.
Journal of Clinical Oncology (2003)

518 Citations

Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

Christopher L. Amling;Robert H. Riffenburgh;Leon Sun;Judd W. Moul.
Journal of Clinical Oncology (2004)

481 Citations

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

Gyorgy Petrovics;Aijun Liu;Syed Shaheduzzaman;Bungo Furasato.
Oncogene (2005)

465 Citations

Prostate specific antigen only progression of prostate cancer

Judd W. Moul.
The Journal of Urology (2000)

436 Citations

PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu.
Proceedings of the National Academy of Sciences of the United States of America (2000)

415 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Judd W. Moul

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 249

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 147

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 138

William J. Aronson

William J. Aronson

University of California, Los Angeles

Publications: 134

Peter T. Scardino

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

Publications: 133

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 129

Anthony V. D'Amico

Anthony V. D'Amico

Brigham and Women's Hospital

Publications: 126

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 121

Martha K. Terris

Martha K. Terris

Augusta University

Publications: 110

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 110

Alan W. Partin

Alan W. Partin

Johns Hopkins University School of Medicine

Publications: 109

James A. Eastham

James A. Eastham

Memorial Sloan Kettering Cancer Center

Publications: 108

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 106

Christopher J. Kane

Christopher J. Kane

University of California, San Diego

Publications: 106

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 96

Michael W. Kattan

Michael W. Kattan

Cleveland Clinic

Publications: 96

Something went wrong. Please try again later.